Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2021-02-05
2021-06-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Furthermore, the release of GI hormones, glycemic control, appetite-related sensations, GI tolerance, sweetness and liking in response to the pre-loads will be investigated.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Erythritol
20 volunteers receive 50g erythritol dissolved in 300mL tap water as an oral pre-load.
Erythritol
50g erythritol dissolved in 300mL tap water.
Sucrose
20 volunteers receive 33.5g sucrose dissolved in 300mL tap water as an oral pre-load.
Sucrose
33.5g sucrose dissolved in 300mL tap water.
Sucralose
20 volunteers receive 0.0558g sucralose dissolved in 300mL tap water as an oral pre-load.
Sucralose
0.0558g sucralose dissolved in 300mL tap water.
Water
20 volunteers receive 300mL tap water as an oral pre-load.
Water
300mL tap water.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Erythritol
50g erythritol dissolved in 300mL tap water.
Sucrose
33.5g sucrose dissolved in 300mL tap water.
Sucralose
0.0558g sucralose dissolved in 300mL tap water.
Water
300mL tap water.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal eating habits (eating breakfast; no diets; no dietary changes; no vegetarians/vegans, no intolerances/allergies)
* Age 18-55 years
* Stable body weight (+/- 5%) for at least three months
* Informed Consent as documented by signature (Appendix Informed Consent Form)
Exclusion Criteria
* Fructose intolerance
* Pre-existing consumption of erythritol and/or sucralose more than once a week
* Substance abuse
* Regular intake of medications, except anticontraceptive
* Chronic or clinically relevant acute infections
* Pregnancy: although no contraindication, pregnancy might influence metabolic state. Women who are pregnant or have the intention to become pregnant during the course of the study are excluded. Female participants of childbearing age have to use safe contraception (oral, injectable, or implantable contraceptives, intrauterine contraceptive devices, or tubectomy). In female participants a urine pregnancy test is carried out upon screening.
* Participation in another study with investigational drug within the 30 days preceding and during the present study.
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne Christin Meyer-Gerspach, PD, PhD
Role: PRINCIPAL_INVESTIGATOR
St. Clara Research Ltd.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Claraspital
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PolyFoodIntake
Identifier Type: -
Identifier Source: org_study_id